Pfizer Inc.'s PFE ABRILADA a biosimilar to Humira has received FDA approval for the treatment of certain patients with rheumatoid arthritis juvenile idiopathic arthritis psoriatic arthritis ankylosing spondylitis adult Crohn's disease ulcerative colitis...
↧